Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$227M |
| 2 |
Microsoft
MSFT
|
+$183M |
| 3 |
Meta Platforms (Facebook)
META
|
+$179M |
| 4 |
PepsiCo
PEP
|
+$149M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$138M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BCR
CR Bard Inc.
BCR
|
+$243M |
| 2 |
LVLT
Level 3 Communications Inc
LVLT
|
+$163M |
| 3 |
KITE
Kite Pharma, Inc.
KITE
|
+$85.5M |
| 4 |
SFR
Starwood Waypoint Homes
SFR
|
+$45.3M |
| 5 |
BRCD
Brocade Communications Systems, Inc. NEW
BRCD
|
+$42.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.85% |
| 2 | Financials | 16.38% |
| 3 | Healthcare | 13.22% |
| 4 | Industrials | 10.47% |
| 5 | Consumer Discretionary | 9.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MXWL
2876
DELISTED
Maxwell Technologies Inc
MXWL
| $1.49M | ﹤0.01% |
258,586
+5,235
| +2% | +$27.2K |
|
|
COOP
2877
DELISTED
Mr. Cooper
COOP
| $1.49M | ﹤0.01% |
145,973
-15
| -0% | -$144 |
|
2878
Standard BioTools
LAB
$309M
| $1.49M | ﹤0.01% |
252,279
+21,429
| +9% | +$117K |
|
|
NVO
2879
Novo Nordisk
NVO
$207B
| $1.49M | ﹤0.01% |
55,370
+2,140
| +4% | +$54.4K |
|
2880
Investar Holding Corp
ISTR
$417M
| $1.48M | ﹤0.01% |
61,580
+792
| +1% | +$18.8K |
|
|
TNAV
2881
DELISTED
Telenav Inc.
TNAV
| $1.48M | ﹤0.01% |
268,764
-1,978
| -0.7% | -$11K |
|
2882
Clarus
CLAR
$146M
| $1.48M | ﹤0.01% |
188,763
+3,306
| +2% | +$24.8K |
|
|
CAJ
2883
DELISTED
Canon, Inc.
CAJ
| $1.48M | ﹤0.01% |
39,450
-121
| -0.3% | -$4.52K |
|
|
LFIN
2884
DELISTED
LongFin Corp Class A Common Stock
LFIN
| $1.47M | ﹤0.01% |
+26,186
| New | +$1.21M |
|
2885
LSI Industries
LYTS
$907M
| $1.47M | ﹤0.01% |
213,590
-36,070
| -14% | -$244K |
|
2886
Oil-Dri
ODC
$1.27B
| $1.47M | ﹤0.01% |
70,614
+1,164
| +2% | +$25.5K |
|
2887
Peoples Bancorp of North Carolina
PEBK
$235M
| $1.46M | ﹤0.01% |
47,631
+770
| +2% | +$24.2K |
|
|
WAAS
2888
DELISTED
AquaVenture Holdings Limited
WAAS
| $1.46M | ﹤0.01% |
94,196
+6,121
| +7% | +$87.8K |
|
2889
LSB Industries
LXU
$719M
| $1.46M | ﹤0.01% |
216,761
+4,620
| +2% | +$29K |
|
|
MBTF
2890
DELISTED
MBT Financial Corporation
MBTF
| $1.46M | ﹤0.01% |
137,585
-6,818
| -5% | -$72.7K |
|
2891
AstraZeneca
AZN
$246B
| $1.46M | ﹤0.01% |
20,969
+944
| +5% | +$63.7K |
|
|
HDNG
2892
DELISTED
Hardinge Inc
HDNG
| $1.45M | ﹤0.01% |
83,393
+1,581
| +2% | +$26.2K |
|
|
SBOW
2893
DELISTED
SilverBow Resources, Inc.
SBOW
| $1.45M | ﹤0.01% |
48,831
+282
| +0.6% | +$6.59K |
|
2894
Orrstown Financial Services
ORRF
$842M
| $1.45M | ﹤0.01% |
57,418
+1,208
| +2% | +$30.5K |
|
|
MBCN
2895
DELISTED
Middlefield Banc Corp
MBCN
| $1.45M | ﹤0.01% |
60,058
+1,016
| +2% | +$23.6K |
|
|
SABA
2896
Saba Capital Income & Opportunities Fund II
SABA
$222M
| $1.45M | ﹤0.01% |
111,944
+76,845
| +219% | +$1.01M |
|
|
REIS
2897
DELISTED
Reis, Inc.
REIS
| $1.45M | ﹤0.01% |
70,061
+920
| +1% | +$17.8K |
|
|
RYZ
2898
Ryerson Holding Corp
RYZ
$1.44B
| $1.45M | ﹤0.01% |
139,035
+16,022
| +13% | +$149K |
|
2899
Carlyle Group
CG
$17.4B
| $1.44M | ﹤0.01% |
62,999
+4,272
| +7% | +$95.5K |
|
|
CASC
2900
DELISTED
Cascadian Therapeutics, Inc.
CASC
| $1.44M | ﹤0.01% |
389,041
+42,439
| +12% | +$174K |
|
Similar funds
Geode Capital Management's Q4 2017 Portfolio in Review
As of Q4 2017, Geode Capital Management held 4,142 positions worth $294B, up 8.7% from $271B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Geode Capital Management's Q4 2017 filing shows 98 new, 2,556 increased, 827 reduced and 120 closed positions. Its largest new stake was Delphi Technologies PLC Ordinary Shares: 742,921 shares worth $39M. The largest sale was CR Bard Inc., an estimated $243M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 742,921 shares worth $39M.
- Geode Capital Management added most to Apple in Q4 2017, an estimated $227M increase.
- Geode Capital Management's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $23.7M.
- Geode Capital Management fully exited CR Bard Inc. in Q4 2017, selling an estimated $243M.
- Geode Capital Management's ten largest holdings make up 17% of its $294B portfolio in Q4 2017.
- Geode Capital Management opened 98 new positions and closed 120 in Q4 2017.
- Geode Capital Management's portfolio value rose 8.7% quarter-over-quarter to $294B.
Based on Geode Capital Management's 13F filing for Q4 2017, filed 13 Feb 2018.